Schedule 13G ownership disclosure
PHOENIX BIOTECH ACQUISITION CORP.
Security class unavailable · CUSIP: 71902K204
Event date: 2021-10-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,230,266
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-21-000577
- Form type
- SC 13G
- Filer
- Beryl Capital Management LLC
- CIK
- CIK 1719307
- Filed
- Oct 18, 2021
- Reporting period
- Oct 06, 2021
- Description
- Schedule 13G beneficial ownership